Elevated cerebrospinal fluid levels of prostaglandin E2 and 15<i>‐(S)‐</i>hydroxyeicosatetraenoic acid in multiple sclerosis
Niklas Mattsson(Malmö University), Domenico Praticò(University of Pennsylvania), Lars Rosengren(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Oluf Andersen(Sahlgrenska University Hospital), Sara Haghighi(Sahlgrenska University Hospital), Henrik Zetterberg(National Hospital for Neurology and Neurosurgery), I. Zho(Temple University), J.‐E. Månsson(University of Gothenburg), M. Yaong(Temple University)
Cited by 40
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k